HLA-A2.1/B2M
品系全名
C57BL/6JSmo-B2mtm1(hB2M-linker-HLA-A*0201/H2-D1)Smoc
目录号
NM-HU-241353
品系状态
活体
基因信息
基因名
B2M
品系描述
验证数据
Fig.1 Detection of hB2M expression in Blood in WT C57BL 6 and HO HLA-A2.1/B2M mice.
Fig.2 Detection of HLA-ABC expression in Blood in WT C57BL/6 and HO HLA-A2.1/B2M mice.
Fig.3 Detection of vaccine-induced immune responses in HLA-A2.1/B2M mice by ELISpot assay.
Under peptide pool stimulation, both WT mice and HLA-A2.1/B2M mice mounted cellular immune responses, with the latter exhibiting stronger responses. Upon stimulation with NY-ESO-1157-165, WT mice showed no response, whereas HLA-A2.1/B2M mice generated a robust cellular immune response, demonstrating that this mouse model can effectively present the hHLA-A2.1-restricted dominant epitope NY-ESO-1157-165.
Fig.4 T-cell intracellular cytokine staining (ICS) assays.
Upon stimulation with the hHLA-A2.1-restricted dominant epitope NY-ESO-1157-165, only HLA-A2.1/B2M mice generated a large number of IFN-γ-positive CD8 T cells.
你也可能感兴趣
Tamoxifen诱导Cre-ERT2小鼠 使用指南
Cre-ERT2在无Tamoxifen诱导的情况下，在细胞质内处于无活性状态；当Tamoxifen诱导后，Tamoxifen的代谢产物4-OHT（雌激素类似物）与ERT结合，可使Cre-ERT2进核发挥Cre重组酶活性。
查看Cre-lox系统介绍及使用汇总
你一定听说过Cre-lox重组系统，无论你是否直接进行过基因操作。由于Cre-lox系统具有操作简单、重组率高的优点，如今已经成为体内外遗传操作的强有力工具。利用Cre-lox系统，可以在特定细胞、组织或整个生物体，甚至在特定时间点敲除或表达某个基因，实现对特定基因的时空特异性操作，这对基因功能的研究和人类疾病动物模型的建立都具有深刻影响。
查看
